jm
cook
tel
fax
mont
antimicrobi
phenol
stilben
e
recent
isol
leav
comptonia
peregrina
l
coulter
shown
possess
inhibitori
activ
sever
gramposit
bacteria
includ
isol
methicillinresist
staphylococcu
aureu
mrsa
mycobacterium
bovi
bcg
avirul
bacillu
anthraci
stern
strain
among
other
result
prompt
design
synthesi
two
new
class
compound
phenoxystyren
phenothiostyren
analog
natur
antimicrobi
stilben
addit
stilbenoid
analog
synthes
use
new
effici
coppermedi
coupl
strategi
minimum
inhibitori
concentr
mic
antimicrobi
assay
perform
compound
prepar
preliminari
structureact
relationship
studi
indic
new
class
synthet
analog
well
stilben
show
promis
activ
gramposit
bacteria
least
one
phenol
moieti
present
absent
potenc
phenol
phenoxystyren
phenothiostyren
found
compar
phenol
stilben
test
elsevi
ltd
right
reserv
part
ongo
ethnopharmacolog
effort
discov
new
molecul
might
use
combat
clinic
signific
bacteri
infect
identifi
phenol
stilben
e
leav
shrub
comptonia
peregrina
l
coulter
sweet
fern
plant
use
tradit
antimicrobi
biolog
properti
number
nativ
north
american
cultur
great
lake
maritim
region
although
cytox
compound
methylpcoumar
previous
found
plant
along
numer
compound
isol
essenti
oil
stilben
previous
report
present
c
peregrina
interestingli
compound
identifi
plant
didymochlaena
truncatala
sw
j
sm
dryopteridacea
alpinia
katsumadai
hayata
howev
antimicrobi
properti
natur
stilben
report
either
prior
studi
purif
natur
product
batteri
minimum
inhibitori
concentr
mic
assay
perform
assess
rang
antimicrobi
activ
analysi
studi
indic
exhibit
select
inhibit
growth
numer
clinic
relev
gramposit
bacteria
reason
low
concentr
exampl
found
inhibit
growth
methicillinresist
staphylococcu
aureu
mrsa
mic
lgml
vancomycinresist
enterococci
vre
mic
lgml
tabl
current
mrsa
vre
two
bacteri
speci
grow
concern
medic
commun
develop
widespread
resist
exist
frontlin
drug
addit
also
show
good
inhibitori
activ
stern
strain
bacillu
anthraci
mic
lgml
attenu
variant
caus
speci
anthrax
well
promis
activ
relat
bacillu
speci
tabl
furthermor
natur
product
found
effect
inhibit
growth
mycobacterium
bovi
mic
lgml
indic
might
serv
promis
lead
scaffold
develop
drug
use
combat
drug
resist
mycobacterium
tuberculosi
infect
organ
medicin
chemist
found
transstilben
scaffold
intrigu
structur
class
compound
eg
see
methoxyl
phenol
stilben
fig
stilben
scaffold
may
consid
privileg
structur
wide
varieti
biolog
activ
inde
e
stilbenoid
compound
wide
distribut
throughout
natur
natur
methoxyl
phenol
stilben
found
numer
medicin
plant
food
product
instanc
natur
phenol
stilben
resveratrol
trihydroxystilben
shown
possess
divers
rang
biolog
potenti
therapeut
properti
specif
resveratrol
relat
substitut
e
stilben
forward
potenti
cancer
chemotherapeut
agent
inhibit
vitro
growth
human
cancer
cell
line
ii
antiinflammatori
agent
act
cyclooxygenas
cox
enzym
inhibit
mechan
iii
antioxid
may
serv
chemoprotect
agent
resveratrol
analog
also
may
prevent
heart
diseas
due
lipid
lower
effect
inhibit
lipid
peroxid
addit
properti
resveratrol
radic
scaveng
neuroprotect
antivir
activ
antibacteri
activ
inhibit
sar
coronaviru
replic
antiplatelet
aggreg
anticarcinogen
activ
antihiv
activ
inhibit
human
cytochrom
recent
document
basi
mani
report
activ
substitut
stilben
resveratrol
well
promis
antimicrobi
studi
natur
stilben
design
synthesi
chemic
novel
analog
compound
undertaken
envis
function
analog
ephenoxystyren
ephenothiostyren
might
fill
role
consequ
new
synthet
approach
develop
creat
new
agent
addit
synthet
method
develop
prepar
phenoxystyren
phenothiostyren
extend
construct
sever
substitut
estilbenoid
analog
explor
structureantimicrobi
activ
relationship
class
compound
relat
greater
detail
initi
decid
prepar
gram
quantiti
activ
natur
stilben
accomplish
use
hornerwadsworthemmon
process
shown
scheme
novel
approach
creat
substitut
stilben
conveni
inexpens
rel
high
yield
easili
produc
gram
quantiti
desir
target
condens
benzyl
bromidederiv
phosphor
basic
condit
yield
mixtur
stilben
z
e
ratio
approxim
scheme
pure
obtain
mixtur
crystal
methanol
water
subsequ
monodemethyl
e
use
bbr
gave
desir
phenol
stilben
good
yield
begin
construct
deriv
sar
studi
practic
synthesi
develop
use
negishi
crosscoupl
process
directli
appli
thiophen
give
scheme
approach
gratifyingli
gave
desir
e
alken
isom
therebi
elimin
need
tediou
separ
unwant
z
isom
importantli
phenol
respect
produc
effici
use
onepot
process
thu
coupl
tbdpsprotect
arylvinyl
iodid
thiophenyl
zinc
reagent
follow
deprotect
use
tbafthf
afford
target
phenol
styrylthiophen
without
requir
extra
demethyl
step
felt
extens
vinyl
linkag
stilben
addit
either
oxygen
sulfur
heteroatom
would
yield
novel
unnatur
phenoxystyren
phenothiostyren
scaffold
might
exhibit
enhanc
antimicrobi
activ
therefor
phenol
phenoxystyren
analog
phenol
phenoxythiostyren
analog
prepar
employ
copper
catalyz
coupl
reaction
recent
develop
laboratori
scheme
process
involv
crosscoupl
aryl
vinyl
iodid
correspond
phenol
thiophenol
similar
fashion
sequenc
outlin
scheme
coppermedi
coupl
reaction
subsequ
deprotect
could
carri
conveni
one
reaction
vessel
overal
approach
provid
effici
highyield
access
new
class
phenol
stilben
analog
motiv
posit
result
obtain
reaction
outlin
scheme
correspond
oxyfunction
dimethoxi
phenoxystyren
phenothiostyren
analog
tabl
minimum
inhibitori
concentr
mic
e
purifi
c
peregrina
sever
speci
bacteria
gram
reaction
mic
lgml
also
prepar
use
copper
mediat
coupl
approach
scheme
crosscoupl
reaction
carri
dimethoxi
aryl
vinyl
iodid
phenol
thiophenol
present
scheme
appar
versatil
coupl
method
class
compound
prompt
modif
asymmetr
phenoxystyren
scaffold
place
hydroxymethoxi
group
phenoxi
ring
rather
styryl
ring
repres
compound
scheme
shown
scheme
oprotect
monophenol
gave
revers
phenol
phenoxystyren
coupl
phenylvinyl
iodid
subsequ
deprotect
similarli
dimethoxi
phenoxystyren
obtain
coupl
compound
prepar
scheme
purifi
flash
column
chromatographi
use
silica
gel
appropri
solvent
system
purif
phenoxystyren
phenothiostyren
target
shown
scheme
stabil
select
agent
evalu
acid
hcl
basic
naoh
neutral
aqueou
media
assess
chemic
stabil
stir
condit
h
found
novel
phenoxi
phenothio
analog
stabl
hydrolysisdegrad
product
observ
solut
tlc
stilben
phenoxystyren
phenothiostyren
target
compound
synthes
illustr
scheme
assay
abil
inhibit
growth
five
select
strain
clinic
signific
bacteria
result
mic
minimum
inhibitori
concentr
assay
present
tabl
vitro
mic
determin
compound
perform
accord
nation
committe
clinic
laboratori
standard
nccl
guidelin
safeti
reason
gramposit
microorgan
bacillu
cereu
mycobacterium
smegmati
use
surrog
virul
strain
b
anthraci
tuberculosi
respect
analog
also
test
abil
inhibit
growth
escherichia
coli
repres
gramneg
microorgan
analysi
result
report
tabl
illustr
number
interest
antimicrobi
structureact
featur
stilbenoid
compound
extend
heteroatomcontain
phenoxystyren
phenothiostyren
analog
expect
none
compound
exhibit
antimicrobi
activ
repres
gramneg
speci
e
coli
line
result
preliminari
assay
perform
use
natur
stilben
gramneg
bacteria
affect
agent
see
data
tabl
examin
data
tabl
clear
presenc
least
one
phenol
group
requir
activ
class
compound
dimethoxyl
compound
devoid
inhibitori
activ
gramposit
gramneg
speci
investig
howev
natur
product
analog
contain
metahydroxi
group
exhibit
inhibitori
activ
gramposit
organ
even
moieti
locat
phenoxi
ring
oppos
styryl
ring
seen
compound
result
surpris
phenol
compound
view
one
major
class
natur
antimicrobi
agent
perhap
excit
find
studi
phenoxystyren
phenothiostyren
analog
phenol
stilben
roughli
equival
potenc
mic
assay
perform
although
none
vinyl
ether
vinyl
thioether
analog
significantli
better
inhibit
growth
gramposit
microorgan
origin
natur
lgml
less
potent
mrsa
lgml
smegmati
lgml
initi
result
highli
encourag
consider
viabil
use
phenoxystyren
phenothiostyren
scaffold
structur
analog
bioactiv
antimicrobi
stilben
treat
diseas
stabl
low
high
ph
valu
inde
novel
scaffold
may
serv
excel
start
point
chemic
optim
develop
new
drug
certainli
need
combat
threaten
mrsa
tuberculosi
anthrax
infect
furthermor
transstilben
shown
possess
divers
array
biolog
activ
find
promot
addit
sar
studi
stilbenoid
compound
addit
therapeut
area
conclus
antibacteri
activ
phenol
e
stilben
isol
c
peregrina
evalu
demonstr
activ
rang
gramposit
bacteria
includ
drug
resist
aureu
enterococci
spp
gramneg
bacteria
importantli
activ
bovi
bcg
b
anthraci
well
three
relat
bacillu
speci
phenol
stilben
scaffold
modifi
aryl
moieti
extend
one
heteroatom
creat
novel
phenoxystyren
phenothiostyren
deriv
agent
also
demonstr
promis
antimicrobi
activ
given
least
one
phenol
moieti
present
compound
consequ
explor
novel
scaffold
warrant
synthet
microbiolog
perspect
addit
sar
studi
novel
homolog
stilbenoid
compound
extens
microbiolog
character
activ
agent
current
underway
